The board of directors of Lansen Pharmaceutical Holdings Limited announced that Mr. Tang Chiu Ping, Raymond (Mr. Tang) will retire as an Independent Non-executive Director of the company and will cease to be the chairman of the Remuneration Committee of the Company and a member of the Audit Committee of the company with effect from 9 April 2019. Mr. Tang has been a director of the Company since April 2010. He has provided valuable advice and support to the company during his tenure of office. After serving the company for 9 years, Mr. Tang would like to retire upon expiration of the service contract to pursue his other endeavor. The Chairman and the Board express their sincere gratitude to Mr. Tang for his service and valuable contribution made to the Company. Following the retirement of Mr. Tang, the board announced that, with effect from 9 April 2019, Mr. Tang will cease to be the chairman of the Remuneration Committee of the company and a member of the Audit Committee of the Company and Mr. Yeung Tak Bun, Allen (an independent non-executive director of the Company, a member of the Remuneration Committee of the company and a member of the Audit Committee of the company) has been appointed as the chairman of the Remuneration Committee.